Reporting CSOP Hang Seng China Enterprises Index Daily (2x) Leveraged Product
Reports
IFRS
Annual
Quarterly
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Финансовый отчет | link | link | link | link | link | link | link | link |
Share
IFRS
Annual
Quarterly
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0 | |||||||||||
| Цена акции ао | 9.66 | 7.09 | 8.57 | 7.67 | 4.44 | 2.61 | 1.73 | 2.45 | 2.93 | 2.93 | 2.83 | -7.98 |
Efficiency
IFRS
Annual
| 2023 | 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | |||||
| Ebit margin, % | 0 | 0 | |||||
| Рентаб EBITDA, % | 0 | 0 | |||||
| Operation Margin, % | 0 | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
